Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Interest Expenses (2017)

Historic Interest Expenses for Crinetics Pharmaceuticals (CRNX) over the last 1 years, with Q4 2017 value amounting to $1000.0.

  • Crinetics Pharmaceuticals' Interest Expenses changed N/A to $1000.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $8000.0 for FY2017, which is 2727.27% down from last year.
  • Latest data reveals that Crinetics Pharmaceuticals reported Interest Expenses of $1000.0 as of Q4 2017.
  • In the past 5 years, Crinetics Pharmaceuticals' Interest Expenses registered a high of $3000.0 during Q2 2017, and its lowest value of $1000.0 during Q4 2017.